The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis

Luca Richeldi, Vincent Cottin, Isabella Annesi-Maesano, Andreas Günther, Liam Galvin, Michael Kreuter, Pippa Powell, Antje Prasse, George Reynolds, Paolo Spagnolo, Claudia Valenzuela, Marlies Wijsenbeek, Wim A. Wuyts, Bruno Crestani

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Rationale for a multinational registry Idiopathic pulmonary fibrosis (IPF) is the most prevalent of rare pulmonary diseases [1], and the most severe of the chronic forms of idiopathic interstitial pneumonias, with rising incidence and prevalence [2–4]. The prognosis for people diagnosed with IPF is a median survival of 3–3.5 years [1].
Original languageEnglish
Pages (from-to)1-6
Number of pages6
JournalEuropean Respiratory Journal
Volume53
DOIs
Publication statusPublished - 2019

Keywords

  • idiopathic pulmonary fibrosis

Fingerprint

Dive into the research topics of 'The Ariane-IPF ERS Clinical Research Collaboration: seeking collaboration through launch of a federation of European registries on idiopathic pulmonary fibrosis'. Together they form a unique fingerprint.

Cite this